107 related articles for article (PubMed ID: 26239559)
1. Association between Osteopontin Promoter Gene Polymorphisms and Haplotypes with Risk of Diabetic Nephropathy.
Cheema BS; Iyengar S; Sharma R; Kohli HS; Bhansali A; Khullar M
J Clin Med; 2015 Jun; 4(6):1281-92. PubMed ID: 26239559
[TBL] [Abstract][Full Text] [Related]
2. Association of an Osteopontin gene promoter polymorphism with susceptibility to diabetic nephropathy in Asian Indians.
Cheema BS; Iyengar S; Ahluwalia TS; Kohli HS; Sharma R; Shah VN; Bhansali A; Sakhuja V; Khullar M
Clin Chim Acta; 2012 Oct; 413(19-20):1600-4. PubMed ID: 22584029
[TBL] [Abstract][Full Text] [Related]
3. The impact of osteopontin promoter polymorphisms on the risk of calcium urolithiasis.
Liu CC; Huang SP; Tsai LY; Wu WJ; Juo SH; Chou YH; Huang CH; Wu MT
Clin Chim Acta; 2010 May; 411(9-10):739-43. PubMed ID: 20144595
[TBL] [Abstract][Full Text] [Related]
4. Associations between the Genetic Polymorphisms of Osteopontin Promoter and Susceptibility to Cancer in Chinese Population: A Meta-Analysis.
Liu Y; Lei H; Zhang J; Wang J; Li K; Dong W
PLoS One; 2015; 10(8):e0135318. PubMed ID: 26267616
[TBL] [Abstract][Full Text] [Related]
5. The implication of osteopontin (OPN) expression and genetic polymorphisms of OPN promoter in oral carcinogenesis.
Chiu YW; Tu HF; Wang IK; Wu CH; Chang KW; Liu TY; Kao SY
Oral Oncol; 2010 Apr; 46(4):302-6. PubMed ID: 20219412
[TBL] [Abstract][Full Text] [Related]
6. OPN gene polymorphisms, rs17524488 GG/G, rs11730582 T/C, and rs9138 C/A, and cancer risk in a Chinese population.
Mi Y; Ren K; Dai F; Zhu L; Feng N
Sci Rep; 2015 Sep; 5():14164. PubMed ID: 26369832
[TBL] [Abstract][Full Text] [Related]
7. Association of SPP1 promoter variants with hip osteoarthritis susceptibility in Chinese population.
Lv C; Li Y; Xu J; Cao H; Li X; Ma B; Ning P; Wang Y; Wang M; Zhu S; Ge Y; Huang S; Jin Y
Gene; 2015 Jun; 564(1):9-13. PubMed ID: 25796600
[TBL] [Abstract][Full Text] [Related]
8. A functional polymorphism in the Eta-1 promoter is associated with allele specific binding to the transcription factor Sp1 and elevated gene expression.
Hummelshoj T; Ryder LP; Madsen HO; Odum N; Svejgaard A
Mol Immunol; 2006 Mar; 43(7):980-6. PubMed ID: 16009426
[TBL] [Abstract][Full Text] [Related]
9. OPN polymorphism is associated with the susceptibility to cervical spondylotic myelopathy and its outcome after anterior cervical corpectomy and fusion.
Wu J; Wu D; Guo K; Yuan F; Ran B
Cell Physiol Biochem; 2014; 34(2):565-74. PubMed ID: 25116355
[TBL] [Abstract][Full Text] [Related]
10. The functional -443T/C osteopontin promoter polymorphism influences osteopontin gene expression in melanoma cells via binding of c-Myb transcription factor.
Schultz J; Lorenz P; Ibrahim SM; Kundt G; Gross G; Kunz M
Mol Carcinog; 2009 Jan; 48(1):14-23. PubMed ID: 18459127
[TBL] [Abstract][Full Text] [Related]
11. Association between promoter polymorphisms of OPN gene and cancer risk: a meta-analysis.
Liu J; He C; Yuan Q; Wang Z; Xing C; Yuan Y
Onco Targets Ther; 2016; 9():87-97. PubMed ID: 26766914
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of interleukin-10 promoter genotypes and haplotypes in determining the susceptibility to nephropathy in type 2 diabetes patients.
Mtiraoui N; Ezzidi I; Kacem M; Ben Hadj Mohamed M; Chaieb M; Haj Jilani AB; Mahjoub T; Almawi WY
Diabetes Metab Res Rev; 2009 Jan; 25(1):57-63. PubMed ID: 19031431
[TBL] [Abstract][Full Text] [Related]
13. ACE variants interact with the RAS pathway to confer risk and protection against type 2 diabetic nephropathy.
Ahluwalia TS; Ahuja M; Rai TS; Kohli HS; Bhansali A; Sud K; Khullar M
DNA Cell Biol; 2009 Mar; 28(3):141-50. PubMed ID: 19108684
[TBL] [Abstract][Full Text] [Related]
14. Serum osteopontin, but not OPN gene polymorphism, is associated with LVH in essential hypertensive patients.
Hou X; Hu Z; Huang X; Chen Y; He X; Xu H; Wang N
J Mol Med (Berl); 2014 May; 92(5):487-95. PubMed ID: 24370940
[TBL] [Abstract][Full Text] [Related]
15. Identification of specific angiotensin-converting enzyme variants and haplotypes that confer risk and protection against type 2 diabetic nephropathy.
Ezzidi I; Mtiraoui N; Kacem M; Chaieb M; Mahjoub T; Almawi WY
Diabetes Metab Res Rev; 2009 Nov; 25(8):717-24. PubMed ID: 19787680
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of novel polymorphisms in the basal promoter of the human transporter, MATE1.
Ha Choi J; Wah Yee S; Kim MJ; Nguyen L; Ho Lee J; Kang JO; Hesselson S; Castro RA; Stryke D; Johns SJ; Kwok PY; Ferrin TE; Goo Lee M; Black BL; Ahituv N; Giacomini KM
Pharmacogenet Genomics; 2009 Oct; 19(10):770-80. PubMed ID: 19745787
[TBL] [Abstract][Full Text] [Related]
17. Association between osteopontin promoter variants and diastolic dysfunction in hypertensive heart in the Japanese population.
Nakayama H; Nagai H; Matsumoto K; Oguro R; Sugimoto K; Kamide K; Ohishi M; Katsuya T; Okamoto H; Maeda M; Komamura K; Azuma J; Rakugi H; Fujio Y
Hypertens Res; 2011 Oct; 34(10):1141-6. PubMed ID: 21796134
[TBL] [Abstract][Full Text] [Related]
18. Association of NOS2 and NOS3 gene polymorphisms with susceptibility to type 2 diabetes mellitus and diabetic nephropathy in the Chinese Han population.
Chen F; Li YM; Yang LQ; Zhong CG; Zhuang ZX
IUBMB Life; 2016 Jul; 68(7):516-25. PubMed ID: 27192959
[TBL] [Abstract][Full Text] [Related]
19. The Association of Transcription Factor 7 like 2 Gene Polymorphism with Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus.
Morgan MF; Salam RF; Rady NH; Alnaggar ARLR; Ammar SH; Ghanem NS
Curr Diabetes Rev; 2020; 16(4):370-375. PubMed ID: 31288725
[TBL] [Abstract][Full Text] [Related]
20. Osteopontin promoter polymorphisms at locus -443 significantly affect the metastasis and prognosis of human hepatocellular carcinoma.
Dong QZ; Zhang XF; Zhao Y; Jia HL; Zhou HJ; Dai C; Sun HJ; Qin Y; Zhang WD; Ren N; Ye QH; Qin LX
Hepatology; 2013 Mar; 57(3):1024-34. PubMed ID: 23079960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
